Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate.
Ghazal KarevanKazem AhmadiRamezan Ali TaheriMahdi Fasihi-RamandiPublished in: Clinical and experimental vaccine research (2021)
The results showed that chimeric antigen-loaded glycine nanoparticles can act as a vaccine candidate for inducing the cellular and humoral immune response against brucellosis.